Disease Information
General Information of the Disease (ID: DIS00414)
Name |
Neurotoxicity
|
---|---|
ICD |
ICD-11: NE61
|
Resistance Map |
Type(s) of Resistant Mechanism of This Disease
EADR: Epigenetic Alteration of DNA, RNA or Protein
Drug Resistance Data Categorized by Drug
Approved Drug(s)
2 drug(s) in total
Bupivacaine
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Key Molecule: Metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA) (Malat1) | [1] | |||
Resistant Disease | Neurotoxicity [ICD-11: NE61.0] | |||
Molecule Alteration | Up-regulation | Interaction |
||
Resistant Drug | Bupivacaine | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
In Vitro Model | SH-SY5Y cells | Abdomen | Homo sapiens (Human) | CVCL_0019 |
Experiment for Molecule Alteration |
Western bloting analysis; Dual luciferase assay; Knockdown assay | |||
Experiment for Drug Resistance |
CCK8 assay; Caspase-3 activity assay | |||
Mechanism Description | Knockdown of LncRNA MALAT1 alleviates bupivacaine-induced neurotoxicity via the miR-101-3p/PDCD4 axis. |
Hydrogen peroxide
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Key Molecule: Long non-protein coding RNA (LOC284930) | [2] | |||
Resistant Disease | Neurotoxicity [ICD-11: NE61.0] | |||
Molecule Alteration | Down-regulation | Expression |
||
Resistant Drug | Hydrogen peroxide | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
In Vitro Model | SH-SY5Y cells | Abdomen | Homo sapiens (Human) | CVCL_0019 |
Experiment for Molecule Alteration |
Overexpression assay; Knockdown assay | |||
Experiment for Drug Resistance |
CCK8 assay; LDH assay; Caspase-3 activity assay | |||
Mechanism Description | Lnc-EPIC1 downregulation mediates H2O2-induced neuronal cell death. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.